DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, reported sales of $2,105,188 for the first fiscal quarter ended September 30, 2007 compared with $1,634,112 for the quarter ended September 30, 2006, an increase of 24.3%.
